How Cell And Gene Therapies Are Reshaping Commercialization Strategies

In this webinar, Carolyn Morgan of PRECISIONeffect moderates an expert panel exploring the challenges of commercializing a cell or gene therapy from industry trailblazers – Francis Pang, VP and Head of Global Market Access at Orchard Therapeutics, Ramesh Arjunji, Vice President Value & Access at AVROBIO, and Jeremy Schafer, Senior Vice President at PRECISIONvalue will share lessons learned from prior launches and discuss how cell and gene therapies are reshaping commercializing strategies. Some of the topics explored will be tensions between cost-effectiveness and affordability, evidence generation strategies and development, and communication to payers and health technology appraisal organizations.